Synthetic Data News

Synthetic Data for Healthcare

How synthetic data is used in healthcare: HIPAA-compliant AI training data, clinical trial simulation, EHR synthesis, and FDA guidance for AI/ML in medical devices.

Healthcare is the highest-stakes domain for synthetic data. Patient records contain some of the most sensitive personal information in existence — yet AI systems for diagnostics, drug discovery, and clinical decision support require large, labeled datasets to train effectively.

Synthetic patient data solves this tension: it replicates the statistical properties of real EHR data — diagnoses, medications, lab values, demographics — without containing any real patient records, making it shareable across institutions and jurisdictions without HIPAA authorization.

HIPAA and Synthetic Patient Data

Synthetic data is not PHI under HIPAA because it contains no information about real individuals. This makes it usable for AI training, software testing, and research sharing without a Business Associate Agreement or patient authorization — a significant compliance advantage for health AI teams.

Clinical Trial Simulation

Pharmaceutical and biotech organizations use synthetic patient populations to simulate clinical trial cohorts, model treatment outcomes, and stress-test statistical analysis pipelines — accelerating trial design while protecting participant privacy.

EHR Synthesis and Data Augmentation

Electronic health record synthesis addresses two persistent problems in health AI: data scarcity for rare conditions and class imbalance in datasets. CTGAN, conditional VAEs, and diffusion models can generate realistic EHR records for underrepresented diagnoses.

FDA Guidance and AI/ML in Medical Devices

The FDA's action plan for AI/ML-based Software as a Medical Device (SaMD) emphasizes transparency in training data and algorithmic accountability. Certified synthetic training data with cryptographic provenance supports the documentation requirements for FDA premarket submissions.

Related Coverage